Farmacosmo S.p.A. (BIT:COSMO)
Italy
· Delayed Price · Currency is EUR 0.4150
+0.0090 (2.22%)
At close: Dec 5, 2025
Farmacosmo Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 58.85 | 63.7 | 72.07 | 66.43 | 58.37 | 44.44 | Upgrade
|
| Other Revenue | 0.39 | 0.41 | 0.36 | 0.16 | 0.12 | 0.04 | Upgrade
|
| Revenue | 59.23 | 64.1 | 72.44 | 66.59 | 58.5 | 44.48 | Upgrade
|
| Revenue Growth (YoY) | -13.10% | -11.51% | 8.79% | 13.83% | 31.51% | 82.96% | Upgrade
|
| Cost of Revenue | 59.31 | 63.1 | 72.04 | 66.42 | 56.67 | 43.08 | Upgrade
|
| Gross Profit | -0.08 | 1.01 | 0.39 | 0.16 | 1.83 | 1.4 | Upgrade
|
| Selling, General & Admin | 0.35 | 0.36 | 0.53 | 0.17 | 0.13 | 0.11 | Upgrade
|
| Amortization of Goodwill & Intangibles | 2.59 | 2.56 | 2.72 | 1.38 | 0.38 | 0.25 | Upgrade
|
| Other Operating Expenses | 0.33 | 0.29 | 0.28 | 0.1 | 0.15 | 0.14 | Upgrade
|
| Operating Expenses | 3.34 | 3.29 | 3.64 | 1.81 | 0.76 | 0.54 | Upgrade
|
| Operating Income | -3.42 | -2.28 | -3.24 | -1.65 | 1.07 | 0.87 | Upgrade
|
| Interest Expense | -1.27 | -1.2 | -0.95 | -0.55 | - | - | Upgrade
|
| Interest & Investment Income | 0.03 | 0.38 | 0.01 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | -0 | -0 | - | -0 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0 | 0 | 0.04 | -0.4 | -0.34 | Upgrade
|
| Pretax Income | -4.65 | -3.1 | -4.18 | -2.16 | 0.66 | 0.52 | Upgrade
|
| Income Tax Expense | 0.11 | -0.03 | -0.25 | -0.15 | 0.25 | 0.15 | Upgrade
|
| Earnings From Continuing Operations | -4.77 | -3.07 | -3.93 | -2 | 0.41 | 0.37 | Upgrade
|
| Net Income to Company | - | -3.07 | -3.93 | -2 | 0.41 | 0.37 | Upgrade
|
| Minority Interest in Earnings | -0.07 | 0.1 | 0.7 | 0.67 | - | - | Upgrade
|
| Net Income | -4.83 | -2.97 | -3.23 | -1.34 | 0.41 | 0.37 | Upgrade
|
| Net Income to Common | -4.83 | -2.97 | -3.23 | -1.34 | 0.41 | 0.37 | Upgrade
|
| Net Income Growth | - | - | - | - | 10.90% | 178.23% | Upgrade
|
| Shares Outstanding (Basic) | 39 | 39 | 39 | - | 30 | - | Upgrade
|
| Shares Outstanding (Diluted) | 39 | 39 | 39 | - | 30 | - | Upgrade
|
| EPS (Basic) | -0.12 | -0.08 | -0.08 | - | 0.01 | - | Upgrade
|
| EPS (Diluted) | -0.12 | -0.08 | -0.08 | - | 0.01 | - | Upgrade
|
| Free Cash Flow | -2.07 | -2.18 | -5.29 | - | -0.43 | 1.71 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.06 | -0.14 | - | -0.01 | - | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.010 | - | Upgrade
|
| Gross Margin | -0.13% | 1.57% | 0.54% | 0.24% | 3.12% | 3.15% | Upgrade
|
| Operating Margin | -5.77% | -3.56% | -4.48% | -2.47% | 1.82% | 1.95% | Upgrade
|
| Profit Margin | -8.16% | -4.64% | -4.46% | -2.01% | 0.71% | 0.84% | Upgrade
|
| Free Cash Flow Margin | -3.50% | -3.40% | -7.31% | - | -0.73% | 3.84% | Upgrade
|
| EBITDA | -1.72 | -0.32 | -0.42 | -1.37 | 1.34 | 1.14 | Upgrade
|
| EBITDA Margin | -2.90% | -0.50% | -0.58% | -2.06% | 2.29% | 2.57% | Upgrade
|
| D&A For EBITDA | 1.7 | 1.96 | 2.83 | 0.28 | 0.28 | 0.28 | Upgrade
|
| EBIT | -3.42 | -2.28 | -3.24 | -1.65 | 1.07 | 0.87 | Upgrade
|
| EBIT Margin | -5.77% | -3.56% | -4.48% | -2.47% | 1.82% | 1.95% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 37.30% | 28.66% | Upgrade
|
| Revenue as Reported | 59.39 | 64.26 | 72.61 | 66.64 | 58.5 | 44.48 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.